Rishi Kumar, MD
Ophthalmology · Louisville, KYNPI 1114970415
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Among ophthalmology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 196 payments — averaging $39.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$822
- Sight Sciences, Inc.$516
- Tarsus Pharmaceuticals, Inc.$502
- Bausch & Lomb Americas Inc.$474
- Glaukos Corporation$472
- Harrow Eye, LLC$417
- plus $5K from 30 others
What the payments were for
- Consulting fees$2553%
- Food & beverage$7,45696%
- Entertainment$731%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 26 | $822 |
| Sight Sciences, Inc. | 12 | $516 |
| Tarsus Pharmaceuticals, Inc. | 10 | $502 |
| Bausch & Lomb Americas Inc. | 17 | $474 |
| Glaukos Corporation | 5 | $472 |
| Harrow Eye, LLC | 7 | $417 |
| Amgen | 3 | $404 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $397 |
| Ocular Therapeutix, Inc. | 28 | $374 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 17 | $350 |
| AbbVie(2 entities) | 17 | $338 |
| Aerie Pharmaceuticals, Inc. | 10 | $269 |
| Shire North American Group Inc | 1 | $255 |
| Regeneron Healthcare Solutions, Inc. | 2 | $219 |
| Sun Pharmaceutical Industries Inc. | 3 | $148 |
| Abiomed | 1 | $146 |
| Astellas Pharma US Inc | 2 | $141 |
| Pfizer | 1 | $135 |
| Oyster Point Pharma, Inc. | 6 | $135 |
| Ivantis, Inc | 1 | $134 |
| Genentech USA, Inc. | 1 | $122 |
| Kala Pharmaceuticals, Inc. | 1 | $120 |
| Ellexiscience | 1 | $120 |
| Merck | 1 | $115 |
| Silk Road Medical, Inc. | 1 | $105 |
| Biotissue Holdings Inc. | 2 | $99 |
| Johnson & Johnson | 1 | $89 |
| NEW World Medical,inc. | 4 | $75 |
| Optos, Inc. | 1 | $73 |
| Iridex Corporation | 1 | $50 |
| Dompe US, Inc. | 2 | $46 |
| Rayner Intraocular Lenses Limited | 2 | $45 |
| Quidel Corporation | 1 | $32 |
| Rxsight Inc | 1 | $16 |
| LKC Technologies, Inc. | 1 | $14 |
| Tearlab Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$398
- VEVYE$344
- XDEMVY$247
- iStent Trabecular Micro-Bypass System Model iS3$142
- TEPEZZA$140
- Tecnis Simplicity$135
- ELIQUIS$135
- Hydrus$134
- PanOptix$128
- Clareon$127
- Clareon PanOptix Pro$125
- VABYSMO$122
- Izervay$121
- INVELTYS$120
- EYLEA$119
- UPLIZNA$117
- DIFICID$115
- ZINPLAVA$115
- DEXTENZA$111
- Rhopressa$110
How this compares
$7,784 in reported general payments places this provider in the 90th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 144 | $72,475 |
| XdemvyLotilaner | 34 | $64,172 |
| RestasisCyclosporine | 45 | $49,147 |
| RhopressaNetarsudil Mesylate | 114 | $46,782 |
| RocklatanNetarsudil Mesylat/Latanoprost | 96 | $37,479 |
| CombiganBrimonidine Tartrate/Timolol | 78 | $25,845 |
| VyzultaLatanoprostene Bunod | 46 | $17,411 |
| MieboPerfluorohexyloctane/Pf | 20 | $16,377 |
| Latanoprost | 1,522 | $11,130 |
| Cyclosporine | 16 | $9,763 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 57 | $9,583 |
| VevyeCyclosporine | 12 | $9,104 |
| Timolol Maleate | 513 | $8,774 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 18 | $7,997 |
| Prednisolone Acetate | 119 | $5,546 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan | $338 | $147,467267 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $269 | $84,262210 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $502 | $64,17234 claims |
| Bausch & Lomb Americas Inc.Vyzulta, Miebo | $474 | $33,78866 claims |
| Harrow Eye, LLCVevye | $417 | $9,10412 claims |
| AlconSimbrinza | $822 | $7,99718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 216 ophthalmology providers in Kentucky.
Other ophthalmology in Louisville
- Jeremy ClarkLouisville$131K
- Guruprasad PattarLouisville$36K
- Gary FoulksLouisville$16K
- Christopher ComptonLouisville$13K
- Inder SingalLouisville$9K
- Frank BurnsLouisville$8K
- Steven BloomLouisville$6K
- Sharmini BalakrishnanLouisville$6K
- Sergei DmitrukLouisville$5K
- Lawrence TenkmanLouisville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.